Published by Coherent Market Insights
Posted on October 4, 2021
Microkeratome is a high-precision surgical instrument used for Laser Eye Surgery (LASIK) and Anterior Lamellar Keratoplasty (ALK). In 1990, the microkeratome was introduced into the equation to result in the LASIK procedure that doctors are using today. Therefore, with the increasing prevalence of eye diseases worldwide, demand for microkeratome is also increasing rapidly. According to the World Health Organization (WHO), refractive errors and uncorrected cataracts are the leading cause of vision impairment. In 2019, around 2.2 billion people suffered from eye disorders or vision impairment. This in turn is expected to augment the growth of the microkeratome market, worldwide.
Request For Sample Copy of This Premium Research Microkeratome Market @
https://www.coherentmarketinsights.com/insight/request-sample/3965
Moreover, according to the WHO, worldwide, one billion people have a vision impairment that could have been prevented or has yet to be addressed. One billion people includes those with moderate or severe distance vision impairment or blindness due to cataract (65.2 million), trachoma (2 million), diabetic retinopathy (3 million), corneal opacities (4.2 million), cataract (65.2 million), unaddressed refractive error (123.7 million), as well as near vision impairment caused by unaddressed presbyopia (826 million). Therefore, there is an increasing demand for microkeratome worldwide, driving the growth of the microkeratome market.
The microkeratome market growth can also be attributed to the growing geriatric population around the world. The geriatric population is highly susceptible to different types of age-related diseases such as macular degeneration (both dry and wet). Moreover, vision loss among the elderly is a major health care problem. Around one in three has some form of vision-reducing eye disease by the age of 65. According to the WHO, by 2050, the world’s population aged 60 years and older is expected to total 2 billion, up from 900 million in 2015. Thus, there is an increasing demand for LASIK and ALK, which in turn increase the demand for microkeratome.
However, growth of the microkeratome market is witnessing a decline due to the emergence of COVID-19 (the global pandemic). This is because ophthalmologists are not seeing patients with COVID-19 and footfall has also decreased in hospitals and diagnostic centers. Moreover, now, people have started adopting new LASIK technologies, such as the use of femtosecond laser for the treatment of various eye diseases. Thus, increasing development and adoption of new LASIK technologies is expected to restrain the microkeratome market growth. Besides, the emergence of photorefractive keratectomy (PRK) is also expected to hinder the demand for LASIK and hence the need for microkeratome devices.
Major Players in Microkeratome Market
Essilor International, Bausch & Lomb Incorporated, Johnson & Johnson Vision Care, CooperVision, Carl Zeiss AG, Hoya Corporation, Alcon, Inc., STAAR Surgical Company, Marvel Medtech, Abbott Medical Optics Inc., Novartis AG, HAAG-Streit Holding AG, Nidek Co., Ltd., Valeant Pharmaceuticals International, Inc., Sonomed Escalon, Topcon Corporation, Gulden Ophthalmics, FCI Ophthalmics, Ziemer Ophthalmic Systems AG, and Glaukos Corporation.
The growth prospects and market estimations in the global Microkeratome market are based on a detailed assessment of opportunities and business factors in different regions. In the course of the analysis, key markets are identified, regions with sluggish growth are highlighted, and geographies with indications of rapid growth have been underlined. Further, the shares of the promising markets in the overall Microkeratome market by the end of the forecast period are laid down, supported by a Microkeratome analysis of the growth dynamics over the next few years.
Ask for PDF sample copy of the Microkeratome market report @
https://www.coherentmarketinsights.com/insight/request-pdf/3965
Microkeratome Market insights will improve the revenue impact of businesses in various industries:
• providing a framework tailored toward understanding the attractiveness quotient of various products/solutions/technologies in the Microkeratome Market
• Guiding stakeholders to identify key problem areas pertaining to their consolidation strategies in the global Microkeratome market and offers solutions
• assessing the impact of changing regulatory dynamics in the regions in which companies are keen on expanding their footprints
• provides an understanding of disruptive technology trends to help businesses make their transitions smoothly
• helping leading companies make strategy recalibrations ahead of their competitors and peers
• Offers insights into promising growth for top players aiming to retain their leadership position in the market & supply-side analysis of the Microkeratome market.
Reasons to Purchase this Report
Buy This Complete A Business Report With Flat US $2000 Off @
https://www.coherentmarketinsights.com/promo/buynow/3965
In conclusion, the Microkeratome market report presents the descriptive analysis of the parent market supported elite players, present, past, and artistic movement information which is in a position to function as a profitable guide for all the Microkeratome industry business competitors. Our expert research analyst’s team has been trained to supply in-depth marketing research reports from every individual sector which can be helpful to know the industry data within the most precise way.
Contact:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027
Email: sales@coherentmarketinsights.com
The post Microkeratome Market – Approval and launch of effective surgical technologies and products is expected to boost the growth of the market appeared first on Gatorledger.
Microkeratome is a high-precision surgical instrument used for Laser Eye Surgery (LASIK) and Anterior Lamellar Keratoplasty (ALK). In 1990, the microkeratome was introduced into the equation to result in the LASIK procedure that doctors are using today. Therefore, with the increasing prevalence of eye diseases worldwide, demand for microkeratome is also increasing rapidly. According to the World Health Organization (WHO), refractive errors and uncorrected cataracts are the leading cause of vision impairment. In 2019, around 2.2 billion people suffered from eye disorders or vision impairment. This in turn is expected to augment the growth of the microkeratome market, worldwide.
Request For Sample Copy of This Premium Research Microkeratome Market @
https://www.coherentmarketinsights.com/insight/request-sample/3965
Moreover, according to the WHO, worldwide, one billion people have a vision impairment that could have been prevented or has yet to be addressed. One billion people includes those with moderate or severe distance vision impairment or blindness due to cataract (65.2 million), trachoma (2 million), diabetic retinopathy (3 million), corneal opacities (4.2 million), cataract (65.2 million), unaddressed refractive error (123.7 million), as well as near vision impairment caused by unaddressed presbyopia (826 million). Therefore, there is an increasing demand for microkeratome worldwide, driving the growth of the microkeratome market.
The microkeratome market growth can also be attributed to the growing geriatric population around the world. The geriatric population is highly susceptible to different types of age-related diseases such as macular degeneration (both dry and wet). Moreover, vision loss among the elderly is a major health care problem. Around one in three has some form of vision-reducing eye disease by the age of 65. According to the WHO, by 2050, the world’s population aged 60 years and older is expected to total 2 billion, up from 900 million in 2015. Thus, there is an increasing demand for LASIK and ALK, which in turn increase the demand for microkeratome.
However, growth of the microkeratome market is witnessing a decline due to the emergence of COVID-19 (the global pandemic). This is because ophthalmologists are not seeing patients with COVID-19 and footfall has also decreased in hospitals and diagnostic centers. Moreover, now, people have started adopting new LASIK technologies, such as the use of femtosecond laser for the treatment of various eye diseases. Thus, increasing development and adoption of new LASIK technologies is expected to restrain the microkeratome market growth. Besides, the emergence of photorefractive keratectomy (PRK) is also expected to hinder the demand for LASIK and hence the need for microkeratome devices.
Major Players in Microkeratome Market
Essilor International, Bausch & Lomb Incorporated, Johnson & Johnson Vision Care, CooperVision, Carl Zeiss AG, Hoya Corporation, Alcon, Inc., STAAR Surgical Company, Marvel Medtech, Abbott Medical Optics Inc., Novartis AG, HAAG-Streit Holding AG, Nidek Co., Ltd., Valeant Pharmaceuticals International, Inc., Sonomed Escalon, Topcon Corporation, Gulden Ophthalmics, FCI Ophthalmics, Ziemer Ophthalmic Systems AG, and Glaukos Corporation.
The growth prospects and market estimations in the global Microkeratome market are based on a detailed assessment of opportunities and business factors in different regions. In the course of the analysis, key markets are identified, regions with sluggish growth are highlighted, and geographies with indications of rapid growth have been underlined. Further, the shares of the promising markets in the overall Microkeratome market by the end of the forecast period are laid down, supported by a Microkeratome analysis of the growth dynamics over the next few years.
Ask for PDF sample copy of the Microkeratome market report @
https://www.coherentmarketinsights.com/insight/request-pdf/3965
Microkeratome Market insights will improve the revenue impact of businesses in various industries:
• providing a framework tailored toward understanding the attractiveness quotient of various products/solutions/technologies in the Microkeratome Market
• Guiding stakeholders to identify key problem areas pertaining to their consolidation strategies in the global Microkeratome market and offers solutions
• assessing the impact of changing regulatory dynamics in the regions in which companies are keen on expanding their footprints
• provides an understanding of disruptive technology trends to help businesses make their transitions smoothly
• helping leading companies make strategy recalibrations ahead of their competitors and peers
• Offers insights into promising growth for top players aiming to retain their leadership position in the market & supply-side analysis of the Microkeratome market.
Reasons to Purchase this Report
Buy This Complete A Business Report With Flat US $2000 Off @
https://www.coherentmarketinsights.com/promo/buynow/3965
In conclusion, the Microkeratome market report presents the descriptive analysis of the parent market supported elite players, present, past, and artistic movement information which is in a position to function as a profitable guide for all the Microkeratome industry business competitors. Our expert research analyst’s team has been trained to supply in-depth marketing research reports from every individual sector which can be helpful to know the industry data within the most precise way.
Contact:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027
Email: sales@coherentmarketinsights.com
The post Microkeratome Market – Approval and launch of effective surgical technologies and products is expected to boost the growth of the market appeared first on Gatorledger.
Explore more articles in the Research Reports category
